+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

South Korea ECG Market by Product Lead and End User: Opportunity Analysis and Industry Forecast, 2017 - 2025

  • PDF Icon

    Report

  • 126 Pages
  • January 2019
  • Region: South Korea
  • Allied Market Research
  • ID: 4828443
ECG market Overview:

Electrocardiograph (ECG) devices are used to record the heart activities through electric signals. These devices are amplified on the ECG monitor. They are essentially adopted across various medical set-ups to diagnose different types of heart diseases and arrhythmias in people; thereby, assisting the appropriate therapy for patients suffering from cardiovascular diseases (CVD). The South Korea ECG market was valued at $2.99 million in 2017 and is expected to reach $7.69 million by 2025, registering a CAGR of 12.3% from 2017 to 2025.

The key factors that drive the market growth include increase in number of CVD patients across South Korea and rise in demand for monitoring systems and portable cardiac rhythm management. In addition, surge in the geriatric population and favorable government regulations regarding the ECG devices supplement the market growth in South Korea. However, high costs associated with sophisticated ECG devices and increase in threat of market saturation are the factors anticipated to restrict the market growth. Conversely, increase in development of wireless communication and cloud computing is expected to provide lucrative opportunities for the growth of the market.

The South Korea ECG market is segmented into product, lead, and end user. Based on product, the market is divided into resting ECG, stress ECG, and Holter monitors. The Holter monitors are further bifurcated into wired and wireless Holter monitors. Based on lead, the market is classified into single lead, 3-6 lead, and 12-lead. Based on end user, it is categorized into hospitals & clinics, home settings & ambulatory surgical centers (ASCs), and others.

Key Market Benefits for ECG market:

The study provides an in-depth analysis of the ECG devices and instruments, with current trends and future estimations to elucidate the imminent investment pockets.
A quantitative analysis from 2017 to 2025 is discussed to enable the stakeholders to capitalize on the prevailing market opportunities.
Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
Porter’s five forces model is expected to interpret the bargaining power of suppliers & buyers, threat of new entrants & substitutes, and competition among the key players.

ECG Key Market Segments:

By Product

Resting ECGs
Stress ECGs
Holter Monitors
Wired Holter Monitors
Wireless Holter Monitors

By Lead

Single Lead
3-6 Lead
12 Lead

By End User

Hospitals & Clinics
Home settings and Ambulatory surgical centers
Others

The list of key players operating in this market includes:

GE Healthcare (General Electric Company)
Bionet Co., Ltd.
Hill Rom Holdings, Inc.
Koninklijke Philips N.V.
Mediana Co., Ltd.
Medtronic Plc.
Mindray Medical International Limited
Nihon Kohden Corporation
OSI Systems Inc.
Schiller AG
CardioComm Solutions, Inc.
AlivCor, Inc.
Qardio, Inc.
Omron Healthcare Europe B.V
Beijing Choice Electronic Technology Co., Ltd. (ChoiceMMed)

The other players included in the value chain analysis (and not included in the report) include:

Trismed Co., Ltd
Johnson & Johnson
Midmark Corporation
Fukuda Denshi Co., Ltd

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top player positioning, 2017
3.4. Porters five forces analysis
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Rise in geriatric population in South Korea
3.5.1.2. Favorable government regulations
3.5.1.3. Technological advancements and portability of ECG devices
3.5.2. Restraints
3.5.2.1. High cost associated with ECG devices
3.5.2.2. Unfavorable economic conditions and market saturation
3.5.3. Opportunity
3.5.3.1. Increase in development of wireless communications and cloud computing
3.6. OTC ECG Devices Market
3.6.1. Overview
3.6.2. Market size and forecast
CHAPTER 4: SOUTH KOREA ELECTROCARDIOGRAPH (ECG) MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Resting ECG
4.2.1. Key market trends and growth opportunities
4.2.2. Market Size & Forecast
4.3. Stress ECG
4.3.1. Key market trends and growth opportunities
4.3.2. Market Size & Forecast
4.4. Holter Monitors
4.4.1. Key market trends and growth opportunities
4.4.2. Market Size and Forecast, by Product Type
4.4.3. Market Size & Forecast
4.4.3.1. Wired Holter monitors
4.4.3.1.1. Market size & forecast
4.4.3.2. Wireless Holter monitors
4.4.3.2.1. Market size & forecast
CHAPTER 5: SOUTH KOREA ELECTROCARDIOGRAPH (ECG) MARKET, BY LEAD
5.1. Overview
5.1.1. Market Size and Forecast
5.2. Single Lead ECG
5.2.1. Market Size & Forecast
5.3. 3-6 Lead ECG
5.3.1. Market Size & Forecast
5.4. 12-Lead ECG
5.4.1. Market Size & Forecast
CHAPTER 6: SOUTH KOREA ELECTROCARDIOGRAPH (ECG) MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals & Clinics
6.2.1. Market Size & Forecast
6.3. Home Settings & Ambulatory Surgical Centers (ASCs)
6.3.1. Market Size & Forecast
6.4. Others
6.4.1. Market Size & Forecast
CHAPTER 7: COMPANY PROFILES
7.1. BIONET CO., LTD.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product Portfolio
7.2. GE HEALTHCARE (GENERAL ELECTRIC)
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product Portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. HILL ROM HOLDINGS, INC.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product Portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. KONINKLIJKE PHILIPS N.V.
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Business performance
7.4.5. Product Portfolio
7.4.6. Key strategic moves and developments
7.5. MEDIANA CO., LTD
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product Portfolio
7.6. MEDTRONIC PLC.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segment
7.6.4. Product Portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments
7.7. MINDRAY MEDICAL INTERNATIONAL LIMITED
7.7.1. Company overview
7.7.2. Operating business segment
7.7.3. Product Portfolio
7.8. NIHON KOHDEN CORPORATION
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product Portfolio
7.8.5. Business performance
7.9. OSI SYSTEMS, INC.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5. Business performance
7.10. SCHILLER AG
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segment
7.10.4. Product Portfolio
7.11. ALIVCOR, INC.
7.11.1. Company overview
7.11.2. Company snapshot
7.11.3. Product Portfolio
7.12. BEIJING CHOICE ELECTRONIC TECHNOLOGY CO., LTD (CHOICEMMED)
7.12.1. Company overview
7.12.2. Company snapshot
7.12.3. Product Portfolio
7.13. CARDIOCOMM SOLUTIONS, INC.
7.13.1. Company overview
7.13.2. Company snapshot
7.13.3. Operating business segment
7.13.4. Product Portfolio
7.14. OMRON HEALTHCARE EUROPE B.V.
7.14.1. Company overview
7.14.2. Company snapshot
7.14.3. Product Portfolio
7.15. QARDIO, INC.
7.15.1. Company overview
7.15.2. Company snapshot
7.15.3. Product Portfolio

Executive Summary

According to this report titled, 'South Korea ECG Market by Product, Lead, and End user: Opportunity Analysis and Industry Forecast, 2018 - 2025' the market was valued at $2.99 million in 2017, and is projected to reach $7.69 million by 2025, growing at a CAGR of 12.3% from 2018 to 2025.

Electrocardiograph (ECG) devices are used to record the heart activities through electric signals. These devices are amplified on the ECG monitor. These are essentially adopted across various medical set-ups to diagnose different types of heart diseases and arrhythmias in people; thereby, assisting the appropriate therapy for patients suffering from cardiovascular diseases (CVD).

The key factors that drive the market growth include increase in number of CVD patients across South Korea and rise in demand for monitoring systems and portable cardiac rhythm management. In addition, surge in the geriatric population and favorable government regulations regarding the ECG devices supplement the market growth in South Korea. However, high costs associated with sophisticated ECG devices and increase in threat of market saturation are the factors anticipated to restrict the market growth. Conversely, increase in development of wireless communication and cloud computing is expected to provide lucrative opportunities for the growth of the market.

The South Korea ECG market is segmented into product, lead, and end user. Based on product, the market is divided into resting ECG, stress ECG, and Holter monitors. The Holter monitors are further bifurcated into wired and wireless Holter monitors. Based on lead, the market is classified into single lead, 3-6 lead, and 12-lead. Based on end user, it is categorized into hospitals & clinics, home settings & ambulatory surgical centers (ASCs), and others.

The hospitals segment led the market with more than two-thirds of the market share in 2017. Electrocardiographs devices majorly find application in most of the hospitals, as they are a useful modality. Sophisticated monitoring systems equipped with high-definition display systems have revolutionized the medical sector, especially wearable ECG systems, by enhancing monitoring efficiency and portability.

Key Findings of the ECG Market:

Based on product, the resting ECG segment accounted for approximately half of the market share in 2017.
Based on end user, the home settings & ambulatory surgical center segment is anticipated to grow at a CAGR of 14.3% from 2018 to 2025.
Based on lead, the 3-6 lead ECGs segment is estimated to grow at the highest CAGR of 12.9% during the forecast period.
Based on lead, the hospitals and clinics segment contributed to two-thirds of the market share in 2017.

The report provides an extensive competitive analysis and profiles of the key market players. The list of players profiled in the report include GE Healthcare (General Electric Company), Bionet Co., Ltd., Hill Rom Holdings, Inc., Koninklijke Philips N.V., Mediana Co., Ltd., Medtronic Plc., Mindray Medical International Limited, Nihon Kohden Corporation, OSI Systems, Inc., Schiller AG, CardioComm Solutions, Inc., AlivCor, Inc., Qardio, Inc., Omron Healthcare Europe B.V., and Beijing Choice Electronic Technology Co., Ltd. (ChoiceMMed). The other players involved in the value chain analysis (but not included in the report) are Trismed Co., Ltd., Medtronic Plc., Johnson & Johnson, Midmark Corporation, and Fukuda Denshi Co., Ltd.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information